Does highly active antiretroviral therapy increase the risk of congenital abnormalities in HIV-infected women? [5]

Journal of Acquired Immune Deficiency Syndromes

Volumn 40, Issue 1, 2005, Pages 116-118

  Patel, Deven ^a   Thorne, Claire ^a   Fiore, Simona ^a   Newell, Marie Louise ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EFAVIRENZ; NUCLEOSIDE ANALOG; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADULT; BLOOD CLOTTING DISORDER; BRAIN MALFORMATION; CATARACT; CLEFT PALATE; CONGENITAL HEART MALFORMATION; CONGENITAL MALFORMATION; DIGESTIVE SYSTEM MALFORMATION; DOWN SYNDROME; DRUG ABUSE; EAR MALFORMATION; ENTERITIS; ESOPHAGUS ATRESIA; FACE MALFORMATION; FEMALE; GENITAL MALFORMATION; GREAT VESSELS TRANSPOSITION; HEART ATRIUM SEPTUM DEFECT; HEART VENTRICLE SEPTUM DEFECT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIP DYSPLASIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYDROCELE; HYDROCEPHALUS; HYDRONEPHROSIS; KIDNEY MALFORMATION; KIDNEY POLYCYSTIC DISEASE; LETTER; LIMB MALFORMATION; MAJOR CLINICAL STUDY; MALE; POLYDACTYLY; PRIORITY JOURNAL; SITUS INVERSUS; STOMACH PERFORATION; TERATOGENICITY; VIRUS LOAD;

ABNORMALITIES, DRUG-INDUCED; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; COHORT STUDIES; DRUG THERAPY, COMBINATION; EUROPE; FEMALE; GESTATIONAL AGE; HIV INFECTIONS; HUMANS; INFANT; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY OUTCOME; PREVALENCE; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 24144477897     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.qai.0000156854.99769.a5     Document Type: Letter

References (6)

1. Dorenbaum A, Cunningham CK, Gelber RD. et al. Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: a randomized trial. JAMA. 2002;288:189-198.
2. European Collaborative Study. Exposure to anti-retroviral therapy in utero or early life: the health of uninfected children born to HIV-infected women. J Acquir Immune Defic Syndr. 2003;32:380-387.
3. European Collaborative Study. Gender and race do not alter early-life determinants of clinical disease progression in HIV-1 vertically infected children. AIDS. 2004;18:509-516.
4. Public Health Service Taskforce. Safety and toxicity of individual antiretroviral agents in pregnancy. Available at: http://AIDSinfo.nih. gov. Accessed August 5, 2004.
5. Antiretroviral Pregnancy Registry Steering Committee. Antiretroviral pregnancy registry interim report for 1st January 1989 to 31st January 2003. Available at: http://www.apregistry. com/who.htm. Accessed August 5, 2004.
6. Covington DL, Conner SD, Doi PA, et al. Risk of birth defects associated with nelfinavir exposure during pregnancy. Obstet Gynecol. 2004;103:1181-1189.